Valuation: Olympus Corporation

Capitalization 2,175B 14.1B 11.85B 10.8B 10.32B 19.09B 1,277B 19.94B 125B 49.97B 615B 52.9B 51.8B P/E ratio 2026 *
24.1x
P/E ratio 2027 * 19.9x
Enterprise value 2,178B 14.13B 11.87B 10.82B 10.34B 19.12B 1,279B 19.98B 126B 50.06B 616B 52.99B 51.89B EV / Sales 2026 *
2.18x
EV / Sales 2027 * 2.05x
Free-Float
94.76%
Yield 2026 *
1.52%
Yield 2027 * 1.62%
1 day+1.88%
1 week+5.95%
Current month+7.28%
1 month-5.30%
3 months+5.53%
6 months+8.25%
Current year-0.48%
1 week 1,827.5
Extreme 1827.5
1,988
1 month 1,801
Extreme 1801
2,137
Current year 1,801
Extreme 1801
2,137
1 year 1,443
Extreme 1443
2,351.5
3 years 1,443
Extreme 1443
2,867
5 years 1,443
Extreme 1443
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 31/05/2025
Director of Finance/CFO 61 31/03/2024
Chief Tech/Sci/R&D Officer 66 -
Director TitleAgeSince
Chairman 69 31/03/2023
Director/Board Member 41 31/05/2019
Director/Board Member 62 31/05/2019
Change 5d. change 1-year change 3-years change Capi.($)
+1.88%+5.95%-12.24%-19.76% 14.1B
-1.27%-5.31%-2.36%-5.53% 203B
+0.47%+3.40%-16.88%+101.88% 176B
+1.43%+1.45%+7.99%-15.10% 155B
+0.18%-18.96%-30.07%+57.21% 110B
+0.15%-3.50%-27.32%-22.93% 54.25B
+0.33%-6.15%+8.37%-0.19% 44.71B
-4.50%+4.82%+10.47%+23.65% 38.39B
+1.18%-2.38%-10.22%-15.44% 36.49B
+0.18%+0.56%-9.46%+14.41% 36.1B
Average +0.05%-3.04%-8.17%+11.82% 86.82B
Weighted average by Cap. +0.09%-4.15%-8.19%+23.13%

Financials

2026 *2027 *
Net sales 999B 6.48B 5.44B 4.96B 4.74B 8.77B 586B 9.16B 57.6B 22.95B 283B 24.29B 23.79B 1,049B 6.8B 5.71B 5.21B 4.97B 9.2B 616B 9.62B 60.48B 24.09B 297B 25.51B 24.98B
Net income 90.4B 586M 493M 449M 429M 794M 53.09B 829M 5.21B 2.08B 25.58B 2.2B 2.15B 110B 714M 600M 547M 522M 966M 64.63B 1.01B 6.35B 2.53B 31.14B 2.68B 2.62B
Net Debt 3.88B 25.18M 21.16M 19.29M 18.42M 34.09M 2.28B 35.61M 224M 89.22M 1.1B 94.45M 92.5M -23.89B -155M -130M -119M -113M -210M -14.03B -219M -1.38B -549M -6.76B -581M -569M
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
29,297
Date Price Change Volume
10/02/26 1,975.00 ¥ +1.88% 3,298,800
09/02/26 1,938.50 ¥ +2.81% 5,542,300
06/02/26 1,885.50 ¥ +1.43% 3,587,500
05/02/26 1,859.00 ¥ -0.05% 3,303,200
04/02/26 1,860.00 ¥ -1.35% 2,085,300
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,975.00JPY
Average target price
2,065.38JPY
Spread / Average Target
+4.58%

Quarterly revenue - Rate of surprise